Oragenics, Inc. (OGEN) Ownership
OGEN ownership summary
as of October 18, 2026- Institutions
- 3.1% of shares outstanding
- Insiders
- 1.93% of shares outstanding
- Shares outstanding
- 4.5M
- Float
- 4.4M shares available to trade
- Short interest
- 18.67% 842K shares short
- Days to cover
- 26.79 short interest up 5.9% vs prior month
- Institutions 3.06%
- Insiders 1.93%
- Other investors 95.01%
OGEN insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-17 | Telling Fred | Buy | $0.29 | 10,084 | $2,924 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
OGEN shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns OGEN
Institutional investors own 3.1% of Oragenics's shares and insiders 1.93%. Short interest is 18.67% of the float, or 26.79 days of average trading volume. The share count rose 6,616.2% since 2014.
Related: OGEN analyst forecast, OGEN key metrics. See the OGEN stock overview for the latest quote and news.
OGEN ownership FAQ
What percentage of Oragenics is owned by institutions?
Institutions hold 3.1% of Oragenics's shares outstanding; insiders hold 1.93%.
What is Oragenics's short interest?
842K shares of Oragenics were sold short, 18.67% of the float; at the average daily volume it would take 26.79 days to cover.
Are insiders buying or selling Oragenics?
Of the latest 1 reported insider transactions in Oragenics (since June 17, 2022), 1 were purchases and 0 were sales.
How many shares of Oragenics are outstanding?
Oragenics has 4.5M shares outstanding, of which 4.4M are in the public float.